204.a Immune monitoring by torque teno virus load in addition to virus-specific T cells after pediatric kidney transplantation
Lars Pape, Germany
204.1 Identification of patients with low likelihood of biopsy-proven acute rejection by donor-derived cell-free DNA and liver function tests in pediatric liver transplant
Mr. Guido Trezeguet Renatti, Argentina
204.2 Pediatric kidney transplantation in infants and low-weight children: What have we learned so far?
Dr. Başak Akyollu, Turkey
204.3 Current allocation policies disadvantage young adults waitlisted after 18 years old for kidney transplantation
Justin A Steggerda, United States
204.4 Major aspects of pediatric liver transplant patient visits to the pediatric emergency department during post-operative follow-up period
Dr. Ayse Gultekingil, Turkey
204.5 Pediatric kidney transplantation in the Middle East: Challenges and solutions
Dr. Bassam Saeed, Syrian Arab Republic
204.6 Precision forecasting of eGFR in pediatric kidney transplant recipients using machine learning
Dr. Meraj Alam Siddiqui, Turkey
204.7 Renal insufficiency causes rapid growth of pediatric kidney graft in a pediatric-to-adult kidney transplantation